600422 昆药集团
已收盘 09-01 15:00:00
资讯
新帖
简况
昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%
证券之星 · 09-01 23:13
昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%
每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会
证券之星 · 08-30 07:36
每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会
昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%
证券之星 · 08-24
昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%
昆药集团最新公告:上半年净亏损3.64亿元同比由盈转亏
证券之星 · 08-21
昆药集团最新公告:上半年净亏损3.64亿元同比由盈转亏
华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%
美股速递 · 08-21
华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%
股市必读:昆药集团(600422)8月10日董秘有最新回复
证券之星 · 08-11
股市必读:昆药集团(600422)8月10日董秘有最新回复
港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售
智通财经 · 07-28
港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售
每周股票复盘:昆药集团(600422)拟减持不超244.3万股东京维立志博
证券之星 · 07-26
每周股票复盘:昆药集团(600422)拟减持不超244.3万股东京维立志博
昆药集团(600422)披露关于所持金融资产处置的公告,7月24日股价下跌3.85%
证券之星 · 07-24
昆药集团(600422)披露关于所持金融资产处置的公告,7月24日股价下跌3.85%
7月24日增减持汇总:ST宁科等8家公司披露增持情况,昆药集团、统一股份披露减持情况(表)
新浪证券 · 07-24
7月24日增减持汇总:ST宁科等8家公司披露增持情况,昆药集团、统一股份披露减持情况(表)
昆药集团:拟减持不超244.3022万股维立志博股票
每日经济新闻 · 07-24
昆药集团:拟减持不超244.3022万股维立志博股票
昆药集团(600422)披露2025年年度权益分派实施公告,7月21日股价下跌4.04%
证券之星 · 07-21
昆药集团(600422)披露2025年年度权益分派实施公告,7月21日股价下跌4.04%
每周股票复盘:昆药集团(600422)半年预亏4亿至3.3亿
证券之星 · 07-19
每周股票复盘:昆药集团(600422)半年预亏4亿至3.3亿
股市必读:昆药集团(600422)预计2026年1-6月归属净利润亏损3.3亿元至4亿元
证券之星 · 07-15
股市必读:昆药集团(600422)预计2026年1-6月归属净利润亏损3.3亿元至4亿元
昆药集团(600422)披露2026年半年度业绩预告,7月14日股价上涨1.48%
证券之星 · 07-14
昆药集团(600422)披露2026年半年度业绩预告,7月14日股价上涨1.48%
每周股票复盘:昆药集团(600422)3款血塞通产品新入基药目录
证券之星 · 07-12
每周股票复盘:昆药集团(600422)3款血塞通产品新入基药目录
昆药集团(600422)披露公司产品新纳入《国家基本药物目录(2026年版)》公告,7月10日股价上涨1.84%
证券之星 · 07-10
昆药集团(600422)披露公司产品新纳入《国家基本药物目录(2026年版)》公告,7月10日股价上涨1.84%
每周股票复盘:昆药集团(600422)高管变动及薪酬制度更新
证券之星 · 07-05
每周股票复盘:昆药集团(600422)高管变动及薪酬制度更新
昆药集团(600422)披露高级管理人员变更公告,6月29日股价上涨4.55%
证券之星 · 06-29
昆药集团(600422)披露高级管理人员变更公告,6月29日股价上涨4.55%
每周股票复盘:昆药集团(600422)拟注册发行不超10亿元债务融资工具
证券之星 · 06-28
每周股票复盘:昆药集团(600422)拟注册发行不超10亿元债务融资工具
加载更多
公司概况
公司名称:
昆药集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-12-06
主营业务:
昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药络泰血塞通系列、蒿甲醚系列、华润圣火理洫王血塞通软胶囊、昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒、贝克诺顿阿尔治玻璃酸钠注射液。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业,全国医药制造业百强企业。
发行价格:
10.22
{"stockData":{"symbol":"600422","market":"SH","secType":"STK","nameCN":"昆药集团","latestPrice":8.62,"timestamp":1788246001000,"preClose":8.57,"halted":0,"volume":4870300,"delay":0,"changeRate":0.0058,"floatShares":757000000,"shares":757000000,"eps":-0.2806,"marketStatus":"已收盘","change":0.05,"latestTime":"09-01 15:00:00","open":8.57,"high":8.65,"low":8.53,"amount":41918800,"amplitude":0.014,"askPrice":8.63,"askSize":359,"bidPrice":8.62,"bidSize":214,"shortable":0,"etf":0,"ttmEps":-0.2806,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.57,"symbolType":"stock","openAndCloseTimeList":[[1788226200000,1788233400000],[1788238800000,1788246000000]],"highLimit":9.43,"lowLimit":7.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":756975757,"isCdr":false,"pbRate":1.34,"roa":"--","roe":"--","epsLYR":0.46,"committee":-0.098067,"marketValue":6525000000,"turnoverRate":0.0064,"status":0,"floatMarketCap":6525000000},"requestUrl":"/m/hq/s/600422","defaultTab":"news","newsList":[{"id":"2664505948","title":"昆药集团(600422)披露2026年第二次临时股东会会议资料,9月1日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664505948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664505948?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:13","pubTimestamp":1788275592,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,昆药集团报收于8.62元,较前一交易日上涨0.58%,最新总市值为65.25亿元。该股当日开盘8.57元,最高8.65元,最低8.53元,成交额达4191.88万元,换手率为0.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804398","title":"每周股票复盘:昆药集团(600422)将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804398","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804398?lang=zh_cn&edition=full","pubTime":"2026-08-30 07:36","pubTimestamp":1788046574,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,昆药集团报收于8.71元,较上周的8.54元上涨1.99%。本周,昆药集团8月26日盘中最高价报8.77元。本周关注点来自公司公告汇总:昆药集团将于2026年9月4日召开2026年半年度业绩说明会。公司公告汇总昆药集团关于召开2026年半年度业绩说明会的公告昆药集团股份有限公司将于2026年9月4日15:00-16:00通过全景路演平台以网络文字互动方式召开2026年半年度业绩说明会,介绍公司2026年半年度经营成果、财务状况,并回答投资者提问。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600422","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220471","title":"昆药集团(600422)披露2026年半年度报告,8月24日股价下跌2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220471?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:13","pubTimestamp":1787566392,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,昆药集团报收于8.31元,较前一交易日下跌2.69%,最新总市值为62.9亿元。该股当日开盘8.48元,最高8.5元,最低8.28元,成交额达7045.24万元,换手率为1.11%。昆药集团于近日披露《2026年半年度报告》。总资产为10,980,313,179.26元,较上年度末减少6.74%;归属于上市公司股东的净资产为4,864,074,777.36元,较上年度末减少9.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","BK0028","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661333291","title":"昆药集团最新公告:上半年净亏损3.64亿元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2661333291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661333291?lang=zh_cn&edition=full","pubTime":"2026-08-21 23:39","pubTimestamp":1787326786,"startTime":"0","endTime":"0","summary":"昆药集团(600422.SH)公告称,2026年上半年,公司实现营业收入16.43亿元,同比下降50.97%;归属于上市公司股东的净利润亏损3.64亿元,上年同期盈利1.98亿元,同比由盈转亏。报告期内,受中成药集中带量采购扩围、医保控费深化及支付改革影响,院内终端产品准入、价格空间持续承压,部分核心品种放量不及预期;院外零售市场竞争格局重构,中小门店加速整合,线上即时零售与电商平台分流效应凸显,线下实体终端销售承压。注:公司Q2净利润亏损2.22亿,Q1净利润-1.42亿,据此计算,Q2净利润环比持续亏损。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100047654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","600422","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186574580","title":"华润医药旗下昆药集团半年营收16.4亿元,同比下滑50.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186574580","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186574580?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:17","pubTimestamp":1787311028,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司近日披露,其下属企业昆药集团在半年报告期内的营业收入为人民币16.4亿元,与去年同期相比,出现了50.97%的显著下降。这一数据反映出该子公司在当前市场环境下面临的挑战与压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0028","600422","BK1191","BK1570","03320","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658520953","title":"股市必读:昆药集团(600422)8月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658520953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658520953?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:32","pubTimestamp":1786383131,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,昆药集团报收于8.81元,下跌0.11%,换手率1.45%,成交量10.98万手,成交额9764.24万元。董秘最新回复投资者: 请问贵公司的新的销售模式渠道销售铺货进展如何?渠道模式转型是长期过程,短期经营压力仍客观存在,公司将脚踏实地落实各项优化举措,全力改善渠道健康度,推动经营的逐步修复。当日关注点交易信息汇总:8月10日主力资金净流出368.16万元,占总成交额3.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0060","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654607680","title":"港股异动 | 维立志博-B(09887)再跌超7% 昆药集团拟减持1.32亿元公司股份 创始人自愿延长禁售","url":"https://stock-news.laohu8.com/highlight/detail?id=2654607680","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654607680?lang=zh_cn&edition=full","pubTime":"2026-07-28 14:14","pubTimestamp":1785219275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,维立志博-B(09887)再跌超7%,截至发稿,跌6.89%,报54.05港元,成交额6.08亿港元。消息面上,7月24日,昆药集团公布,拟减持不超过244.3022万股维立志博股票。预计交易金额约1.32亿元。值得注意的是,本次减持刚好为维立志博解禁前夕。同时,维立志博联合创始人康小强博士表示,自愿延长其直接持有全部约787.5万股H股的禁售期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","09887","BK0188","BK0028","BK0060","BK4585","HK0000252160.HKD","600422","BK4588","HK0000500386.USD","VXUS","BK1161","HK0000252152.HKD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057251","title":"每周股票复盘:昆药集团(600422)拟减持不超244.3万股东京维立志博","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057251?lang=zh_cn&edition=full","pubTime":"2026-07-26 03:02","pubTimestamp":1785006138,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,昆药集团报收于8.73元,较上周的8.95元下跌2.46%。本周,昆药集团7月20日盘中最高价报9.19元。本周关注点公司公告汇总:昆药集团拟通过集中竞价或大宗交易减持不超过244.3022万股南京维立志博股份。昆药集团为进一步强化主业、优化资产结构,拟通过集中竞价、大宗交易等方式择机减持不超过244.3022万股南京维立志博生物科技股份有限公司股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","HK0000500386.USD","09887","BK0188","HK0000252152.HKD","BK0060","BK0028","HK0000252160.HKD","600422","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033917","title":"昆药集团(600422)披露关于所持金融资产处置的公告,7月24日股价下跌3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653033917?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:45","pubTimestamp":1784904317,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,昆药集团报收于8.73元,较前一交易日下跌3.85%,最新总市值为66.08亿元。该股当日开盘9.01元,最高9.12元,最低8.7元,成交额达8946.66万元,换手率为1.33%。近日,昆药集团发布《关于所持金融资产处置的公告》。本次减持已获公司第十一届二十一次董事会审议通过,不构成关联交易和重大资产重组。交易实施期限为禁售期满后12个月内,最终交易作价和实施时间存在不确定性,目前无法确切预计对公司业绩的具体影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","600422","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653508013","title":"7月24日增减持汇总:ST宁科等8家公司披露增持情况,昆药集团、统一股份披露减持情况(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653508013","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653508013?lang=zh_cn&edition=full","pubTime":"2026-07-24 21:45","pubTimestamp":1784900700,"startTime":"0","endTime":"0","summary":"据不完全统计,7月24日盘后,包括ST宁科、青岛啤酒、温氏股份、中国宝安、北汽蓝谷、渤海汽车、泰禾智能、福田汽车在内的8家A股上市公司披露增持情况;昆药集团、统一股份披露减持情况。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:孙同怀","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-24/doc-iniixnfz4835270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0227","BK0081","BK0177","BK0077","BK0174","BK0004","600422","BK0070","BK0275","BK0135","BK0028","BK0229","BK0060","600165","600506","BK0102","BK0042","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653108307","title":"昆药集团:拟减持不超244.3022万股维立志博股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2653108307","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653108307?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:48","pubTimestamp":1784886520,"startTime":"0","endTime":"0","summary":"【昆药集团:拟减持不超244.3022万股维立志博股票】7月24日,昆药集团公告称,为进一步强化主业、优化资产结构,公司拟通过集中竞价、大宗交易等方式择机减持不超过244.3022万股维立志博股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607243820568626.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607243820568626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09887","BK1161","HK0000252152.HKD","600422","BK0188","HK0000500386.USD","HK0000252160.HKD","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653991205","title":"昆药集团(600422)披露2025年年度权益分派实施公告,7月21日股价下跌4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653991205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653991205?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:22","pubTimestamp":1784643759,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘,昆药集团报收于8.78元,较前一交易日下跌4.04%,最新总市值为66.46亿元。该股当日开盘9.14元,最高9.18元,最低8.78元,成交额达1.45亿元,换手率为2.14%。近日,昆药集团发布2025年年度权益分派实施公告:每股派发现金红利0.18元(含税),股权登记日为2026年7月29日,除权(息)日为2026年7月30日,现金红利发放日为2026年7月30日。本次利润分配以公司总股本756,975,757股为基数,共派发现金红利136,255,636.26元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422","BK0060","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230892","title":"每周股票复盘:昆药集团(600422)半年预亏4亿至3.3亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230892","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230892?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:13","pubTimestamp":1784398389,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,昆药集团报收于8.95元,较上周的8.28元上涨8.09%。本周,昆药集团7月16日盘中最高价报9.3元。本周关注点来自业绩披露要点:昆药集团预计2026年上半年归属净利润亏损3.3亿元至4亿元。公司公告汇总昆药集团股份有限公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元,扣除非经常性损益后的净利润为-43,000万元到-35,000万元,较上年同期由盈转亏。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","600422","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651548365","title":"股市必读:昆药集团(600422)预计2026年1-6月归属净利润亏损3.3亿元至4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651548365?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:50","pubTimestamp":1784051419,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,昆药集团报收于8.91元,上涨1.48%,换手率2.98%,成交量22.54万手,成交额2.01亿元。业绩披露要点:昆药集团预计2026年1-6月归属净利润亏损3.3亿元至4亿元,扣非后净利润亏损3.5亿元至4.3亿元。公司公告汇总昆药集团2026年半年度业绩预告昆药集团股份有限公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元,扣除非经常性损益后的净利润为-43,000万元到-35,000万元,较上年同期出现大幅下滑并由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810412","title":"昆药集团(600422)披露2026年半年度业绩预告,7月14日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651810412?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:26","pubTimestamp":1784039176,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,昆药集团报收于8.91元,较前一交易日上涨1.48%,最新总市值为67.45亿元。该股当日开盘8.73元,最高9.08元,最低8.52元,成交额达2.01亿元,换手率为2.98%。近日,昆药集团股份有限公司披露2026年半年度业绩预告。公告显示,公司预计2026年半年度实现归属于上市公司股东的净利润为-40,000万元到-33,000万元,扣除非经常性损益后的净利润为-43,000万元到-35,000万元,较上年同期出现大幅下滑并由盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600422","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892152","title":"每周股票复盘:昆药集团(600422)3款血塞通产品新入基药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892152","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650892152?lang=zh_cn&edition=full","pubTime":"2026-07-12 03:22","pubTimestamp":1783797730,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,昆药集团报收于8.28元,较上周的8.27元上涨0.12%。本周,昆药集团7月6日盘中最高价报8.63元。7月10日盘中最低价报7.96元。昆药集团当前最新总市值62.68亿元,在中药板块市值排名32/66,在两市A股市值排名2655/5202。公司共57个产品进入该目录,新增3个产品。血塞通系列为核心中成药,2025年相关产品销售收入约90,242.25万元,占公司营业收入的13.72%。此次纳入将提升产品在基层医疗市场的可及性,支持慢病管理和银发健康战略。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","BK0060","600422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650136978","title":"昆药集团(600422)披露公司产品新纳入《国家基本药物目录(2026年版)》公告,7月10日股价上涨1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650136978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650136978?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:48","pubTimestamp":1783694896,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,昆药集团报收于8.28元,较前一交易日上涨1.84%,最新总市值为62.68亿元。近日,昆药集团发布关于公司产品新纳入《国家基本药物目录》的公告。根据国家卫生健康委员会等部门发布的通知,昆药集团股份有限公司的络泰血塞通软胶囊、控股子公司昆明华润圣火药业有限公司的理洫王血塞通软胶囊、昆药集团血塞通药业股份有限公司的络泰血塞通滴丸新纳入《国家基本药物目录》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000045023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","600422","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694203","title":"每周股票复盘:昆药集团(600422)高管变动及薪酬制度更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694203","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649694203?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:57","pubTimestamp":1783191428,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,昆药集团报收于8.27元,较上周的7.7元上涨7.4%。本周,昆药集团7月2日盘中最高价报8.53元。来自公司公告汇总:昆药集团通过2026年董事及高管薪酬方案,绩效年薪占比不低于60%。公司公告汇总昆药集团董事会于2026年6月29日收到刘军锋先生的书面辞职报告,其因个人原因申请辞去公司高级副总裁职务,辞任后不再担任公司任何职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600422","BK0239","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647308861","title":"昆药集团(600422)披露高级管理人员变更公告,6月29日股价上涨4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647308861","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647308861?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:40","pubTimestamp":1782744026,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,昆药集团报收于8.05元,较前一交易日上涨4.55%,最新总市值为60.94亿元。该股当日开盘7.66元,最高8.14元,最低7.45元,成交额达8338.21万元,换手率为1.4%。近日,昆药集团发布《关于高级管理人员变更的公告》。公告显示,公司董事会于2026年6月29日收到刘军锋先生的书面辞职报告,因其个人原因申请辞去公司高级副总裁职务,辞任后不再担任公司任何职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","600422","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646431531","title":"每周股票复盘:昆药集团(600422)拟注册发行不超10亿元债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2646431531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646431531?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:13","pubTimestamp":1782587589,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,昆药集团报收于7.7元,较上周的8.09元下跌4.82%。本周,昆药集团6月23日盘中最高价报8.34元。6月26日盘中最低价报7.7元,股价触及近一年最低点。昆药集团当前最新总市值58.29亿元,在中药板块市值排名32/66,在两市A股市值排名2814/5206。会议听取了三位独立董事的述职报告。董事会总结了2025年在战略发展、公司治理、风险防控等方面的工作,并提出了2026年工作计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","600422","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788279881990,"stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.01},{"period":"6month","weight":-0.2606},{"period":"1year","weight":-0.3835},{"period":"ytd","weight":-0.3}],"compareEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.0385},{"period":"3month","weight":-0.0255},{"period":"6month","weight":-0.0313},{"period":"1year","weight":0.0269},{"period":"ytd","weight":0.0028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"昆药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"52182人(较上一季度减少6.10%)","perCapita":"14506股","listingDate":"2000-12-06","address":"云南省昆明市五华区国家高新技术产业开发区科医路166号","registeredCapital":"75697万元","survey":" 昆药集团股份有限公司的主营业务是药物研发、生产及销售、医药流通及大健康产业。公司的主要产品是昆药络泰血塞通系列、蒿甲醚系列、华润圣火理洫王血塞通软胶囊、昆中药参苓健脾胃颗粒、舒肝颗粒、香砂平胃颗粒、贝克诺顿阿尔治玻璃酸钠注射液。公司是国家认定企业技术中心、国家高新技术创新示范企业、国家知识产权示范企业,全国医药制造业百强企业。","listedPrice":10.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昆药集团,600422,昆药集团股票,昆药集团股票老虎,昆药集团股票老虎国际,昆药集团行情,昆药集团股票行情,昆药集团股价,昆药集团股市,昆药集团股票价格,昆药集团股票交易,昆药集团股票购买,昆药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昆药集团(600422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昆药集团(600422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}